Statistically significant lower risk is seen for ICU admission, hospitalization, recovery, and viral clearance. 3 studies from 3 independent teams (all from the same country) show significant improvements.
Meta analysis using the most serious outcome reported shows 38% [20‑51%] lower risk. Results are similar for Randomized Controlled Trials.
No treatment or intervention is 100% effective. All practical, effective, and safe means should be used based on risk/benefit analysis. Multiple treatments are typically used in combination, and other treatments may be more effective. Phthalocyanine may affect the natural microbiome, especially with prolonged use.
All data to reproduce this paper and sources are in the appendix.
Covid Analysis et al., Oct 2024, preprint, 1 author.
